PHARMA-TRADE A/S — Credit Rating and Financial Key Figures
CVR number: 87339815
Skaaremosevej 11-14, Blistrup 3230 Græsted
rsa@persano.dk
Income statement (kDKK)
2023 | 2024 | |
---|---|---|
Fiscal period length | 12 | 12 |
Net sales | ||
Gross profit | ||
Costs of management | -42.22 | -82.28 |
EBIT | -42.22 | -82.28 |
Other financial income | 2 347.29 | 2 578.74 |
Other financial expenses | -29.59 | - 116.17 |
Net income from associates (fin.) | 32 578.67 | 41 294.46 |
Pre-tax profit | 34 854.16 | 43 674.75 |
Income taxes | - 500.43 | - 532.56 |
Net earnings | 34 353.72 | 43 142.18 |
Assets (kDKK)
2023 | 2024 | |
---|---|---|
Intangible assets total | ||
Tangible assets total | ||
Holdings in group member companies | 175 436.16 | 194 989.96 |
Investments total | 175 436.16 | 194 989.96 |
Non-current loans receivable | 562.93 | 550.67 |
Long term receivables total | 562.93 | 550.67 |
Inventories total | ||
Current amounts owed by group member comp. | 61 747.24 | 63 279.53 |
Current other receivables | 5.33 | 16.33 |
Current deferred tax assets | 8 709.01 | 11 562.50 |
Short term receivables total | 70 461.58 | 74 858.36 |
Cash and bank deposits | 4 943.91 | 2 407.61 |
Cash and cash equivalents | 4 943.91 | 2 407.61 |
Balance sheet total (assets) | 251 404.58 | 272 806.60 |
Equity and liabilities (kDKK)
2023 | 2024 | |
---|---|---|
Share capital | 3 000.00 | 3 000.00 |
Shares repurchased | 30 000.00 | 40 000.00 |
Other reserves | 120 445.86 | 139 999.66 |
Retained earnings | 63 585.00 | 46 644.26 |
Profit of the financial year | 34 353.72 | 43 142.18 |
Shareholders equity total | 251 384.58 | 272 786.10 |
Non-current liabilities total | ||
Current trade creditors | 20.00 | 20.50 |
Current liabilities total | 20.00 | 20.50 |
Balance sheet total (liabilities) | 251 404.58 | 272 806.60 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.